A skin reaction to pindololum, a beta-blocking drug
Palatsi, R.
Annals of Clinical Research 8(4): 239-240
1976
ISSN/ISBN: 0003-4762 PMID: 136920 Document Number: 105218
The case is described of a man aged 61, who developed a psoriasiform skin reaction to pindololum after taking 5 mg b.i.d. for seven days. The dermatitis reappeared after resumption of the drug on two occasions. The histology showed a lichenoid eruption.
Document emailed within 1 workday
Related Documents
Bauer, G.E.; Michell, G. 1970: Oxprenolol: clinical experiences with a new beta-adrenergic blocking drug Medical Journal of Australia 1(4): 170-173Chalmers, J.; Wing, L.; West, M.; Bune, A.; Johnston, C.; Jackson, B.; McGrath, B.; Mashford, M.L.; Heath, W.; Westwood, B. 1987: Felodipine compared to prazosin as additional therapy to a beta-blocking drug Journal of Cardiovascular Pharmacology 10(Suppl 10): S82-S84
Pyörälä, K.; Mattila, S.; Leirisalo, M.; Toivonen, S. 1976: The antihypertensive effect of a new beta-blocking drug timolol in combination with hydrochlorothiazide Duodecim; Laaketieteellinen Aikakauskirja 92(11): 588-596
Moore, G.E.; O'Donnell, S.R. 1970: A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole Journal of Pharmacy and Pharmacology 22(3): 180-188
Batlle, F.; Carreño, C.A.; Guetta, N.J.; Vassolo, E.; Bertolasi, C.A. 1970: Treatment of cardiac arrhythmias using a beta adrenergic receptor blocking drug Prensa Medica Argentina 57(38): 1801-1808
Jäättelä, A.; Pyöräiä, K. 1976: The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone Duodecim; Laaketieteellinen Aikakauskirja 92(11): 597-603
Cerasola, G.A.; Botta, R.M.; Riolo, A.; Amico, L.M. 1979: Efficacy of a new beta-blocking drug (atenolol, ICi 66082) in treating arterial hypertension Bollettino Della Societa Italiana di Cardiologia 24(5): 493-500
Nakahara, H.; Nakazawa, M.; Tsukada, T.; Imai, S. 1985: Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits Archives Internationales de Pharmacodynamie et de Therapie 277(2): 253-263
Pentel, P.R.; Salerno, D.M. 1990: Cardiac drug toxicity: digitalis glycosides and calcium-channel and beta-blocking agents Medical Journal of Australia 152(2): 88-94
De Ambroggi, L.; Perotta, G.M.; Satolli, R.; Lotto, A. 1977: Evaluation of the effects of a beta-blocking drug (moprolol) on hemodynamics and lesion potentials in acute myocardial infarct Bollettino Della Societa Italiana di Cardiologia 22(8): 1343-1351
Motolese, M. 1970: Factorial design in a balanced incomplete block in the evaluation of the minimal active dose of a beta-blocking drug Bollettino Chimico Farmaceutico 109(6): 363-368
1979: Adverse Drug Reactions Advisory Committee. Peyronie's disease. A complication in therapy with beta-adrenoreceptor blocking drugs? Medical Journal of Australia 2(8): 432
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Planz, G.; Haass, H.; Lamberts, B. 1982: Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol International Journal of Clinical Pharmacology Therapy and Toxicology 20(10): 469-473
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Nakamura, T.; Hosohata, Y.; Hosohata, K.; Hattori, K.; Suzuki, J.; Nagatomo, T. 1999: Relationship between hydrophobicity and beta-blocking potencies, affinities or dissociation of beta-blockers from beta-adrenoceptors Research Communications in Molecular Pathology and Pharmacology 106(3): 203-211
Eteiba, H.; Hutton, I.; Foale, R.A.; Akhras, F.; Jackson, G.; Prescott, R.J.; Hallam, R.J.; Quinn, K.J. 1991: Acute and chronic effects of once-daily isosorbide-5-mononitrate on the exercise capacity of patients with angina pectoris treated with a beta-blocking drug British Journal of Clinical Practice 45(3): 185-188
Jorde, W.; Schata, M. 1976: Inhibitory effect of beta-adrenergic stimulants on the histamine reaction in human skin. I. Studies with fenoterol Arzneimittel-Forschung 26(11): 2103-2105
Andersen, G.S.; Hartling, O.J.; Hein, H.O.; Leth, A. 1985: Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions Danish Medical Bulletin 32(5): 280-283
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317